Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Explore effective ways to increase your cash back earnings on credit cards. Unlock potential savings with smart strategies.
24,913 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
A quarterly filing may seem dry, but it can reveal game-changing shifts in ultra-wealthy portfolios. This article exp...
Tuesday’s market action centers on fresh analyst calls for Albemarle, Booz Allen Hamilton, Cigna, DT Midstream, GE Ve...
A new mega-listing grabbed headlines by raising $26.5 billion, ranking just below SpaceX in U.S. market history. Read...
Today’s move in redwire stock popped today reflects a developing narrative around space infrastructure and NASA's new...
SpaceX stock soaring has turned heads in the investment world, but chasing momentum can be risky. This guide breaks d...
A 20-year-old data analyst managing two jobs, a new gym venture with $80,000 in debt, and a newborn faces a burnout c...
AI excitement has investors chasing the next big thing. Yet a cautionary line attributed to Sam Altman still echoes i...
Copper prices surge to multi-year highs as supply tightness persists. Four copper miners under $30 are showing signs ...
Rising private valuations for SpaceX are fueling chatter about a Tesla takeover. Market participants say the odds spa...
Three dividend ETFs designed for conservative retirees blend income with risk management, offering low fees and high-...
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...